Granahan Investment Management - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 126 filers reported holding CARIBOU BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
Granahan Investment Management ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$651,887
+21.4%
136,378
+8.0%
0.02%
+35.3%
Q2 2023$536,762
-16.9%
126,297
+3.8%
0.02%
-15.0%
Q1 2023$645,962
-55.3%
121,650
-47.2%
0.02%
-54.5%
Q4 2022$1,446,541
-42.4%
230,341
-3.3%
0.04%
-46.3%
Q3 2022$2,513,000
+3.1%
238,204
-47.0%
0.08%
-1.2%
Q2 2022$2,438,000
-7.4%
449,055
+56.6%
0.08%
+27.7%
Q1 2022$2,632,000
+112.4%
286,672
+249.1%
0.06%
+150.0%
Q4 2021$1,239,000
-63.4%
82,127
-42.1%
0.03%
-59.4%
Q3 2021$3,388,000141,9510.06%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q1 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders